CD2 and Wilson disease: Specifically, WD was associated with low‐grade mucosal (NF‐ĸB expression) and systemic (hs‐CRP) inflammation, increased serum MPO, mucosal lymphocyte apoptosis, mucosal dysbiosis, and fecal BA dysmetabolism compared with parameters assessed in canine biological samples from periods CD1 and CD2.